234 related articles for article (PubMed ID: 27404695)
1. Serum pentraxin 3 levels are negatively associated with carotid intima media thickness in non-obese rheumatoid arthritis patients.
Kahlow BS; Petisco R; Skare TL; Goeldner I; Nisihara RM; Messias-Reason IJ
Int J Cardiol; 2016 Oct; 221():298-301. PubMed ID: 27404695
[TBL] [Abstract][Full Text] [Related]
2. Plasma pentraxin 3 is associated with progression of radiographic joint damage, but not carotid atherosclerosis, in female rheumatoid arthritis patients: 3-year prospective study.
Asanuma YF; Aizaki Y; Noma H; Yokota K; Matsuda M; Kozu N; Takebayashi Y; Nakatani H; Hasunuma T; Kawai S; Mimura T
Mod Rheumatol; 2020 Nov; 30(6):959-966. PubMed ID: 31615315
[No Abstract] [Full Text] [Related]
3. Pentraxin 3 (PTX3) plasma levels and carotid intima media thickness progression in the general population.
Baragetti A; Knoflach M; Cuccovillo I; Grigore L; Casula M; Garlaschelli K; Mantovani A; Wick G; Kiechl S; Willeit J; Bottazzi B; Catapano AL; Norata GD
Nutr Metab Cardiovasc Dis; 2014 May; 24(5):518-23. PubMed ID: 24462365
[TBL] [Abstract][Full Text] [Related]
4. Serum pentraxin 3 and interleukin-6 are associated with subclinical atherosclerosis in recent-onset rheumatoid arthritis.
Mabrouk MM; Ghazy MA; Hassan TM
Egypt J Immunol; 2010; 17(
